EndoClot Plus, Inc. (EPI) is a privately founded company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, EPI developed a breakthrough technology to control bleeding in the gastrointestinal tract (GIT) by spraying a unique and proprietary powder directly to the wound during endoscopy.the hemostatic powder directly to the wound during endoscopy.
| Website | http://endoclot.com |
| Revenue | $5 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2014 |
| Address | 5201 Great America Pkwy Ste 526, Santa Clara, California 95054, US |
| Phone | +1 408-980-9125 |
| Fax | (408) 980-9237 |
| Industry | Manufacturing General, Health Care, Therapeutic Devices, Manufacturing, Medical, Medical Device |
| Keywords | Bleeding Control, Endoscopy, Wound Closure, Minimally Invasive, Medical Technology, Drug Delivery, Clinical Trials |
| Competitors | BIOS Medical, Precision Endoscopic Technologies LLC, COGENT THERAPEUTICS, LLC, Southeastern Medical Technologies (view competitors) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular EndoClot Plus employee's phone or email?
EndoClot Plus Questions
The EndoClot Plus annual revenue was $5 million in 2026.
EndoClot Plus is based in Santa Clara, California.
The NAICS codes for EndoClot Plus are [339, 33].
The SIC codes for EndoClot Plus are [38, 384].
